Share

April 25, 2017; 88 (17) Article

Viral hepatitis and Parkinson disease

A national record-linkage study

Julia Pakpoor, Alastair Noyce, Raph Goldacre, Marianna Selkihova, Stephen Mullin, Anette Schrag, Andrew Lees, Michael Goldacre
First published March 29, 2017, DOI: https://doi.org/10.1212/WNL.0000000000003848
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
295

Share

Article Information

vol. 88 no. 17 1630-1633
DOI: 
https://doi.org/10.1212/WNL.0000000000003848
PubMed: 
28356465
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received June 29, 2016
  • Accepted in final form January 25, 2017
  • First Published March 29, 2017.

Article Versions

Copyright & Usage: 
© 2017 American Academy of Neurology

Author Disclosures

    1. Julia Pakpoor, BA, BM BCh*,
    2. Alastair Noyce, MRCP, PhD*,
    3. Raph Goldacre, MSc,
    4. Marianna Selkihova, MRCP, PhD,
    5. Stephen Mullin, BSc, MRCP,
    6. Anette Schrag, FRCP, PhD,
    7. Andrew Lees, FRCP, MD and
    8. Michael Goldacre, FFPH, FRCP
  1. Julia Pakpoor, BA, BM BCh*,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Alastair Noyce, MRCP, PhD*,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. (1) Britannia Pharmaceuticals, honoraria (2) Office octopus, honoraria (3) Global Kinetics Corporation, honoraria

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Elan pharmaceuticals (2) GE Healthcare

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) Parkinson's UK

    Stock/Stock Options/Board of Directors Compensation:

    1. (1) Lifelab Online

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Raph Goldacre, MSc,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Marianna Selkihova, MRCP, PhD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Stephen Mullin, BSc, MRCP,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. (1) Shire pharmaceutical, Honoraria for presentation at conference (?1000)

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. (1) Honoraria for conference presentation (Shire - ?1000)

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Anette Schrag, FRCP, PhD,
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Member of the editorial boards of Parkinsonism and Related Disorders and Movement Disorders

    Patents:

    1. NONE

    Publishing Royalties:

    1. Rating Scales in Parkinson's disease. Oxford University Press, 2012

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Medtronic Grunenthal

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. Astra Zeneca stocks

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Andrew Lees, FRCP, MD and
    8. Scientific Advisory Boards:

    1. Britannia, UCB phrama, Teva, Lundbeck, BIAL, Roche, Nordiclnfu Care, NeuroDerm, Decision Resources

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Britannia, UCB pharma, Teva, Lundbeck, BIAL, Roche, Nordiclnfu Care, NeuroDerm, Decision Resources

    Editorial Boards:

    1. 2006 Archivas de Nevropsiquiatria (Brazil) 1995-03 Co-Editor in Chief, Movement Disorders Journal and Historical Section Editor 1994-98 Founder Editor, Behavioural Neurology 1994- Neurologia Espana 1994-00 Revista Neurologica, Argentina 1994-95 European Journal of Neurology 1993-Revue Neurologique 1993-03 Brain 1991-95 Journal Neurology, Neurosurgery & Psychiatry 1989-95 Journal of Neurology 1988-95 Journal of Neural Transmission

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Institute of Neurology, UCL

    Consultancies:

    1. Britannia Pharmaceutical, BIAL Portela

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Frances and Renee Hock Fund

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Michael Goldacre, FFPH, FRCP
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Unit of Health-Care Epidemiology (J.P., R.G., M.G.), Nuffield Department of Population Health, University of Oxford; and UCL Institute of Neurology (A.N., M.S., S.M., A.S., A.L.), Queen Square, London, UK.
  1. Correspondence to Dr. Goldacre: michael.goldacre{at}dph.ox.ac.uk
View Full Text

Article usage

Article usage: March 2017 to April 2023

AbstractFullPdfSource
Mar 20171859017Highwire
Apr 201734361688Highwire
May 20179461744Highwire
Jun 2017280313Highwire
Jul 2017136612Highwire
Aug 201721448Highwire
Sep 201711785Highwire
Oct 201714125Highwire
Nov 2017116109Highwire
Dec 201711823Highwire
Jan 201812833Highwire
Feb 201842767Highwire
Mar 201811811Highwire
Apr 201814161Highwire
May 201812414Highwire
Jun 201810833Highwire
Jul 20188702Highwire
Aug 20188710Highwire
Sep 20188403Highwire
Oct 201814533Highwire
Nov 201811735Highwire
Dec 201812411Highwire
Jan 201911756Highwire
Feb 20198212Highwire
Mar 20196210Highwire
Apr 20198200Highwire
May 20195900Highwire
Jun 20197223Highwire
Jul 20196711Highwire
Aug 20196022Highwire
Sep 20195724Highwire
Oct 20195022Highwire
Nov 20197713Highwire
Dec 20194711Highwire
Jan 20206923Highwire
Feb 20205511Highwire
Mar 20206770Highwire
Apr 20203834Highwire
May 20203312Highwire
Jun 20204111Highwire
Jul 20203300Highwire
Aug 20204710Highwire
Sep 20203511Highwire
Oct 20204020Highwire
Nov 20203310Highwire
Dec 20203600Highwire
Jan 20212001Highwire
Feb 20217300Highwire
Mar 20217311Highwire
Apr 20218200Highwire
May 202112620Highwire
Jun 20217400Highwire
Jul 20219110Highwire
Aug 202110011Highwire
Sep 20213811Highwire
Oct 20217835Highwire
Nov 20214720Highwire
Dec 20216210Highwire
Jan 20226200Highwire
Feb 20227111Highwire
Mar 20224852Highwire
Apr 20224100Highwire
May 20224811Highwire
Jun 20223000Highwire
Jul 20224101Highwire
Aug 20224211Highwire
Sep 20222210Highwire
Oct 20223021Highwire
Nov 20224401Highwire
Dec 20225101Highwire
Jan 20234212Highwire
Feb 20233720Highwire
Mar 20234611Highwire
Apr 20236511Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me

Recommended articles